President Trump’s Justice Department will defend Biden’s Inflation Reduction Act and its dangerous price controls on ...

Pharmaceutical manufacturers are padding their wallets while rural families and retirees are squeezed by a system designed to benefit shareholders, not patients,” writes Tonja Hanson in an op-ed.

The Maryland Senate passed legislation Thursday that would expand the authority of the state's Prescription Drug ...

The government program, known as 340B, allows hospitals that care for many uninsured and low-income patients to purchase ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

The second cycle of negotiations will take place under President Donald Trump's administration. The U.S. government has said ...

In a precedential opinion issued on March 6, the Federal Circuit affirmed the US District Court for the Eastern District of Virginia that the ...

The area, where the F.Q. Story, Encanto-Palmcroft, Del Norte, Fairview Place and Woodland neighborhoods are located, had a 33 ...

The new bill would also require state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) as a way to ...

"If a big medicine brand (from US or Europe) is sold in India at a very high price, a large section of our society cannot afford it...Tariffs (in India) are in any case between 0% and 10% and on most ...

But none of the actions affected drug price caps that were enacted under Biden, as the post claims. Caps on vaccines and insulin costs for Medicare recipients were instituted under the Inflation ...